KETOROLAC INJECTION

ACTION: Analgesic/antipyretic
•  Non-selective COX inhibitor, which slows the production of prostaglandins (mediators of the

inflammatory response causing pain and fever) by competitively blocking the enzyme
cycloocxgenase (COX).

INDICATIONS:
•  Mild to moderate pain as described by patients with a pain scale score of 6 or less.

CONTRAINDICATIONS:
•  Known allergy or hypersensitivity to NSAIDS
•  Acute significant trauma (see notes)
•  Acute neurologic symptoms (including focal weakness, paresthesias or other stroke

symptoms)
•  Hemophilia
•  Pregnant or high possibility of pregnancy as reported by patient
•  History of GI bleeding or ulcers
•  Current aspirin or anticoagulation therapy
•  History of renal disease, or kidney transplant
•  Age < 18 years old or > 65 years old
•  Hypotension
•  Current steroid use
•  History of asthma

POTENTIAL SIDE EFFECTS:
•  Diarrhea
•  Abdominal pain
•

Increased risk of GI bleeding

•  Nausea / Vomiting
•  Drowsiness
•  Tinnitus (ringing in the ears)

ADULT DOSE/ROUTE:
  Dose: 15 mg IV/IO* bolus or 30 mg IM.

*IV preferred route

PEDIATRIC DOSE/ROUTE:
  Do Not Use in Patients Under Age 18
NOTES:
•  Clinically evaluate patients to determine if pain score can be administered. If pain score
cannot be administered due to patient condition (severe pain) consider alternates to
ketorolac.
Significant trauma consists of injuries requiring trauma center destination criteria, or those
as a result of which the paramedic is concerned for internal/difficult to control hemorrhage.

•

 Effective: 10/29/18
 Supersedes: New

15

